APA (7th ed.) Citation

Hundemer, M., Klein, U., Hose, D., Raab, M., Cremer, F. W., Jauch, A., . . . Goldschmidt, H. (2007). Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14). Bone marrow transplantation, 40(11), . https://doi.org/10.1038/sj.bmt.1705857

Chicago Style (17th ed.) Citation

Hundemer, Michael, et al. "Lack of CD56 Expression on Myeloma Cells Is Not a Marker for Poor Prognosis in Patients Treated by High-dose Chemotherapy and Is Associated with Translocation T(11;14)." Bone Marrow Transplantation 40, no. 11 (2007). https://doi.org/10.1038/sj.bmt.1705857.

MLA (9th ed.) Citation

Hundemer, Michael, et al. "Lack of CD56 Expression on Myeloma Cells Is Not a Marker for Poor Prognosis in Patients Treated by High-dose Chemotherapy and Is Associated with Translocation T(11;14)." Bone Marrow Transplantation, vol. 40, no. 11, 2007, https://doi.org/10.1038/sj.bmt.1705857.